Trial Profile
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-YH4808 Following Single Oral Dose Administration in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2014
Price :
$35
*
At a glance
- Drugs YH 4808 (Primary)
- Indications Gastro-oesophageal reflux; NSAID-induced ulcer
- Focus Pharmacokinetics
- Sponsors Yuhan
- 15 Apr 2013 New trial record